Global Piezoelectric Extracorporeal Shock Wave Therapy Device 麻豆原创 Growth 2025-2031

Publication ID:

LPI02260896

Publication Date:

February 21, 2025

Pages:

117

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Piezoelectric Extracorporeal Shock Wave Therapy Device market size is predicted to grow from US$ 898 million in 2025 to US$ 1160 million in 2031; it is expected to grow at a CAGR of 4.4% from 2025 to 2031.
Piezoelectric extracorporeal shock wave therapy is a medical device that uses the piezoelectric effect to generate high-energy shock waves, which are transmitted to the lesion site of the human body to promote tissue repair and relieve pain. It is commonly used to treat musculoskeletal system diseases such as fasciitis and tendinitis, and is non-invasive and non-traumatic. This technology promotes blood circulation and accelerates the recovery process through high-frequency vibration stimulation.

United States market for Piezoelectric Extracorporeal Shock Wave Therapy Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Piezoelectric Extracorporeal Shock Wave Therapy Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Piezoelectric Extracorporeal Shock Wave Therapy Device is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Piezoelectric Extracorporeal Shock Wave Therapy Device players cover ULforce, Richard Wolf, Storz Medical, SWISS, Gymna, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淧iezoelectric Extracorporeal Shock Wave Therapy Device Industry Forecast鈥� looks at past sales and reviews total world Piezoelectric Extracorporeal Shock Wave Therapy Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Piezoelectric Extracorporeal Shock Wave Therapy Device sales for 2025 through 2031. With Piezoelectric Extracorporeal Shock Wave Therapy Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Piezoelectric Extracorporeal Shock Wave Therapy Device industry.
This Insight Report provides a comprehensive analysis of the global Piezoelectric Extracorporeal Shock Wave Therapy Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Piezoelectric Extracorporeal Shock Wave Therapy Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Piezoelectric Extracorporeal Shock Wave Therapy Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Piezoelectric Extracorporeal Shock Wave Therapy Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Piezoelectric Extracorporeal Shock Wave Therapy Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Piezoelectric Extracorporeal Shock Wave Therapy Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Tabletop Type
Portable Type
Segmentation by Application:
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
ULforce
Richard Wolf
Storz Medical
SWISS
Gymna
DermoEquipos
EMS
Enraf-Nonius
DJO
MTS
Zimmer MedizinSysteme
GZ LONGEST
Xiangyu Medical
Dornier MedTech
Key Questions Addressed in this Report
What is the 10-year outlook for the global Piezoelectric Extracorporeal Shock Wave Therapy Device market?
What factors are driving Piezoelectric Extracorporeal Shock Wave Therapy Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Piezoelectric Extracorporeal Shock Wave Therapy Device market opportunities vary by end market size?
How does Piezoelectric Extracorporeal Shock Wave Therapy Device break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Piezoelectric Extracorporeal Shock Wave Therapy Device Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Piezoelectric Extracorporeal Shock Wave Therapy Device by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Piezoelectric Extracorporeal Shock Wave Therapy Device by Country/Region, 2020, 2024 & 2031
2.2 Piezoelectric Extracorporeal Shock Wave Therapy Device Segment by Type
2.2.1 Tabletop Type
2.2.2 Portable Type
2.3 Piezoelectric Extracorporeal Shock Wave Therapy Device Sales by Type
2.3.1 Global Piezoelectric Extracorporeal Shock Wave Therapy Device Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Piezoelectric Extracorporeal Shock Wave Therapy Device Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Piezoelectric Extracorporeal Shock Wave Therapy Device Sale Price by Type (2020-2025)
2.4 Piezoelectric Extracorporeal Shock Wave Therapy Device Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Piezoelectric Extracorporeal Shock Wave Therapy Device Sales by Application
2.5.1 Global Piezoelectric Extracorporeal Shock Wave Therapy Device Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Piezoelectric Extracorporeal Shock Wave Therapy Device Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Piezoelectric Extracorporeal Shock Wave Therapy Device Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Piezoelectric Extracorporeal Shock Wave Therapy Device Breakdown Data by Company
3.1.1 Global Piezoelectric Extracorporeal Shock Wave Therapy Device Annual Sales by Company (2020-2025)
3.1.2 Global Piezoelectric Extracorporeal Shock Wave Therapy Device Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Piezoelectric Extracorporeal Shock Wave Therapy Device Annual Revenue by Company (2020-2025)
3.2.1 Global Piezoelectric Extracorporeal Shock Wave Therapy Device Revenue by Company (2020-2025)
3.2.2 Global Piezoelectric Extracorporeal Shock Wave Therapy Device Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Piezoelectric Extracorporeal Shock Wave Therapy Device Sale Price by Company
3.4 Key Manufacturers Piezoelectric Extracorporeal Shock Wave Therapy Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Piezoelectric Extracorporeal Shock Wave Therapy Device Product Location Distribution
3.4.2 Players Piezoelectric Extracorporeal Shock Wave Therapy Device Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Piezoelectric Extracorporeal Shock Wave Therapy Device by Geographic Region
4.1 World Historic Piezoelectric Extracorporeal Shock Wave Therapy Device 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Piezoelectric Extracorporeal Shock Wave Therapy Device Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Piezoelectric Extracorporeal Shock Wave Therapy Device Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Piezoelectric Extracorporeal Shock Wave Therapy Device 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Piezoelectric Extracorporeal Shock Wave Therapy Device Annual Sales by Country/Region (2020-2025)
4.2.2 Global Piezoelectric Extracorporeal Shock Wave Therapy Device Annual Revenue by Country/Region (2020-2025)
4.3 Americas Piezoelectric Extracorporeal Shock Wave Therapy Device Sales Growth
4.4 APAC Piezoelectric Extracorporeal Shock Wave Therapy Device Sales Growth
4.5 Europe Piezoelectric Extracorporeal Shock Wave Therapy Device Sales Growth
4.6 Middle East & Africa Piezoelectric Extracorporeal Shock Wave Therapy Device Sales Growth
5 Americas
5.1 Americas Piezoelectric Extracorporeal Shock Wave Therapy Device Sales by Country
5.1.1 Americas Piezoelectric Extracorporeal Shock Wave Therapy Device Sales by Country (2020-2025)
5.1.2 Americas Piezoelectric Extracorporeal Shock Wave Therapy Device Revenue by Country (2020-2025)
5.2 Americas Piezoelectric Extracorporeal Shock Wave Therapy Device Sales by Type (2020-2025)
5.3 Americas Piezoelectric Extracorporeal Shock Wave Therapy Device Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Piezoelectric Extracorporeal Shock Wave Therapy Device Sales by Region
6.1.1 APAC Piezoelectric Extracorporeal Shock Wave Therapy Device Sales by Region (2020-2025)
6.1.2 APAC Piezoelectric Extracorporeal Shock Wave Therapy Device Revenue by Region (2020-2025)
6.2 APAC Piezoelectric Extracorporeal Shock Wave Therapy Device Sales by Type (2020-2025)
6.3 APAC Piezoelectric Extracorporeal Shock Wave Therapy Device Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Piezoelectric Extracorporeal Shock Wave Therapy Device by Country
7.1.1 Europe Piezoelectric Extracorporeal Shock Wave Therapy Device Sales by Country (2020-2025)
7.1.2 Europe Piezoelectric Extracorporeal Shock Wave Therapy Device Revenue by Country (2020-2025)
7.2 Europe Piezoelectric Extracorporeal Shock Wave Therapy Device Sales by Type (2020-2025)
7.3 Europe Piezoelectric Extracorporeal Shock Wave Therapy Device Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Piezoelectric Extracorporeal Shock Wave Therapy Device by Country
8.1.1 Middle East & Africa Piezoelectric Extracorporeal Shock Wave Therapy Device Sales by Country (2020-2025)
8.1.2 Middle East & Africa Piezoelectric Extracorporeal Shock Wave Therapy Device Revenue by Country (2020-2025)
8.2 Middle East & Africa Piezoelectric Extracorporeal Shock Wave Therapy Device Sales by Type (2020-2025)
8.3 Middle East & Africa Piezoelectric Extracorporeal Shock Wave Therapy Device Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Piezoelectric Extracorporeal Shock Wave Therapy Device
10.3 Manufacturing Process Analysis of Piezoelectric Extracorporeal Shock Wave Therapy Device
10.4 Industry Chain Structure of Piezoelectric Extracorporeal Shock Wave Therapy Device
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Piezoelectric Extracorporeal Shock Wave Therapy Device Distributors
11.3 Piezoelectric Extracorporeal Shock Wave Therapy Device Customer
12 World Forecast Review for Piezoelectric Extracorporeal Shock Wave Therapy Device by Geographic Region
12.1 Global Piezoelectric Extracorporeal Shock Wave Therapy Device 麻豆原创 Size Forecast by Region
12.1.1 Global Piezoelectric Extracorporeal Shock Wave Therapy Device Forecast by Region (2026-2031)
12.1.2 Global Piezoelectric Extracorporeal Shock Wave Therapy Device Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Piezoelectric Extracorporeal Shock Wave Therapy Device Forecast by Type (2026-2031)
12.7 Global Piezoelectric Extracorporeal Shock Wave Therapy Device Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 ULforce
13.1.1 ULforce Company Information
13.1.2 ULforce Piezoelectric Extracorporeal Shock Wave Therapy Device Product Portfolios and Specifications
13.1.3 ULforce Piezoelectric Extracorporeal Shock Wave Therapy Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 ULforce Main Business Overview
13.1.5 ULforce Latest Developments
13.2 Richard Wolf
13.2.1 Richard Wolf Company Information
13.2.2 Richard Wolf Piezoelectric Extracorporeal Shock Wave Therapy Device Product Portfolios and Specifications
13.2.3 Richard Wolf Piezoelectric Extracorporeal Shock Wave Therapy Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Richard Wolf Main Business Overview
13.2.5 Richard Wolf Latest Developments
13.3 Storz Medical
13.3.1 Storz Medical Company Information
13.3.2 Storz Medical Piezoelectric Extracorporeal Shock Wave Therapy Device Product Portfolios and Specifications
13.3.3 Storz Medical Piezoelectric Extracorporeal Shock Wave Therapy Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Storz Medical Main Business Overview
13.3.5 Storz Medical Latest Developments
13.4 SWISS
13.4.1 SWISS Company Information
13.4.2 SWISS Piezoelectric Extracorporeal Shock Wave Therapy Device Product Portfolios and Specifications
13.4.3 SWISS Piezoelectric Extracorporeal Shock Wave Therapy Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 SWISS Main Business Overview
13.4.5 SWISS Latest Developments
13.5 Gymna
13.5.1 Gymna Company Information
13.5.2 Gymna Piezoelectric Extracorporeal Shock Wave Therapy Device Product Portfolios and Specifications
13.5.3 Gymna Piezoelectric Extracorporeal Shock Wave Therapy Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Gymna Main Business Overview
13.5.5 Gymna Latest Developments
13.6 DermoEquipos
13.6.1 DermoEquipos Company Information
13.6.2 DermoEquipos Piezoelectric Extracorporeal Shock Wave Therapy Device Product Portfolios and Specifications
13.6.3 DermoEquipos Piezoelectric Extracorporeal Shock Wave Therapy Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 DermoEquipos Main Business Overview
13.6.5 DermoEquipos Latest Developments
13.7 EMS
13.7.1 EMS Company Information
13.7.2 EMS Piezoelectric Extracorporeal Shock Wave Therapy Device Product Portfolios and Specifications
13.7.3 EMS Piezoelectric Extracorporeal Shock Wave Therapy Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 EMS Main Business Overview
13.7.5 EMS Latest Developments
13.8 Enraf-Nonius
13.8.1 Enraf-Nonius Company Information
13.8.2 Enraf-Nonius Piezoelectric Extracorporeal Shock Wave Therapy Device Product Portfolios and Specifications
13.8.3 Enraf-Nonius Piezoelectric Extracorporeal Shock Wave Therapy Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Enraf-Nonius Main Business Overview
13.8.5 Enraf-Nonius Latest Developments
13.9 DJO
13.9.1 DJO Company Information
13.9.2 DJO Piezoelectric Extracorporeal Shock Wave Therapy Device Product Portfolios and Specifications
13.9.3 DJO Piezoelectric Extracorporeal Shock Wave Therapy Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 DJO Main Business Overview
13.9.5 DJO Latest Developments
13.10 MTS
13.10.1 MTS Company Information
13.10.2 MTS Piezoelectric Extracorporeal Shock Wave Therapy Device Product Portfolios and Specifications
13.10.3 MTS Piezoelectric Extracorporeal Shock Wave Therapy Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 MTS Main Business Overview
13.10.5 MTS Latest Developments
13.11 Zimmer MedizinSysteme
13.11.1 Zimmer MedizinSysteme Company Information
13.11.2 Zimmer MedizinSysteme Piezoelectric Extracorporeal Shock Wave Therapy Device Product Portfolios and Specifications
13.11.3 Zimmer MedizinSysteme Piezoelectric Extracorporeal Shock Wave Therapy Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Zimmer MedizinSysteme Main Business Overview
13.11.5 Zimmer MedizinSysteme Latest Developments
13.12 GZ LONGEST
13.12.1 GZ LONGEST Company Information
13.12.2 GZ LONGEST Piezoelectric Extracorporeal Shock Wave Therapy Device Product Portfolios and Specifications
13.12.3 GZ LONGEST Piezoelectric Extracorporeal Shock Wave Therapy Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 GZ LONGEST Main Business Overview
13.12.5 GZ LONGEST Latest Developments
13.13 Xiangyu Medical
13.13.1 Xiangyu Medical Company Information
13.13.2 Xiangyu Medical Piezoelectric Extracorporeal Shock Wave Therapy Device Product Portfolios and Specifications
13.13.3 Xiangyu Medical Piezoelectric Extracorporeal Shock Wave Therapy Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Xiangyu Medical Main Business Overview
13.13.5 Xiangyu Medical Latest Developments
13.14 Dornier MedTech
13.14.1 Dornier MedTech Company Information
13.14.2 Dornier MedTech Piezoelectric Extracorporeal Shock Wave Therapy Device Product Portfolios and Specifications
13.14.3 Dornier MedTech Piezoelectric Extracorporeal Shock Wave Therapy Device Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Dornier MedTech Main Business Overview
13.14.5 Dornier MedTech Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.